BIT 4.55% 2.1¢ biotron limited

$10 Billion Deal, page-6252

  1. 2,888 Posts.
    lightbulb Created with Sketch. 306
    Vasan, who heads the CSIRO's Dangerous Pathogens Team, said, "Aside from fuelling the essential vaccine preclinical studies, it will accelerate the development and evaluation of therapeutics to complement vaccines."
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.